BG51051A3 - Process for production of b avermektins - Google Patents
Process for production of b avermektins Download PDFInfo
- Publication number
- BG51051A3 BG51051A3 BG082657A BG8265788A BG51051A3 BG 51051 A3 BG51051 A3 BG 51051A3 BG 082657 A BG082657 A BG 082657A BG 8265788 A BG8265788 A BG 8265788A BG 51051 A3 BG51051 A3 BG 51051A3
- Authority
- BG
- Bulgaria
- Prior art keywords
- radical
- compound
- atss
- optionally substituted
- chain
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 108010046716 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) Proteins 0.000 abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 241001468227 Streptomyces avermitilis Species 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 238000000855 fermentation Methods 0.000 abstract 2
- 230000004151 fermentation Effects 0.000 abstract 2
- 125000004070 6 membered heterocyclic group Chemical group 0.000 abstract 1
- 239000005660 Abamectin Substances 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 230000000590 parasiticidal effect Effects 0.000 abstract 1
- 239000002297 parasiticide Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
- C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Fodder In General (AREA)
- Enzymes And Modification Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US651287A | 1987-01-23 | 1987-01-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG51051A3 true BG51051A3 (en) | 1993-01-15 |
Family
ID=21721247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG082657A BG51051A3 (en) | 1987-01-23 | 1988-01-18 | Process for production of b avermektins |
Country Status (30)
| Country | Link |
|---|---|
| EP (2) | EP0276103B1 (de) |
| JP (2) | JPH0681757B2 (de) |
| KR (2) | KR900004419B1 (de) |
| CN (1) | CN1056883C (de) |
| AR (1) | AR241798A1 (de) |
| AT (2) | ATE96174T1 (de) |
| AU (2) | AU595673B2 (de) |
| BG (1) | BG51051A3 (de) |
| BR (1) | BR8800271A (de) |
| CZ (1) | CZ279782B6 (de) |
| DD (2) | DD290214A5 (de) |
| DE (2) | DE3884973T2 (de) |
| DK (2) | DK28988A (de) |
| EG (1) | EG18797A (de) |
| ES (2) | ES2059498T3 (de) |
| FI (2) | FI90091C (de) |
| GR (1) | GR3007586T3 (de) |
| HU (2) | HU201973B (de) |
| IE (2) | IE61066B1 (de) |
| IL (2) | IL85118A (de) |
| IN (1) | IN167980B (de) |
| MA (1) | MA21160A1 (de) |
| MY (1) | MY103514A (de) |
| NZ (2) | NZ223271A (de) |
| PL (2) | PL156763B1 (de) |
| PT (2) | PT86583B (de) |
| RU (1) | RU1806198C (de) |
| SK (1) | SK279351B6 (de) |
| YU (1) | YU47878B (de) |
| ZA (3) | ZA88448B (de) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4806527A (en) * | 1987-03-16 | 1989-02-21 | Merck & Co., Inc. | Avermectin derivatives |
| US4874749A (en) * | 1987-07-31 | 1989-10-17 | Merck & Co., Inc. | 4"-Deoxy-4-N-methylamino avermectin Bla/Blb |
| EP0313297B1 (de) * | 1987-10-23 | 1993-05-19 | Pfizer Inc. | Verfahren zur Herstellung von Aglykonen von Avermectin und sie enthaltende Kulturen |
| GB8807280D0 (en) * | 1988-03-26 | 1988-04-27 | Pfizer Ltd | Antiparasitic agents |
| GB8811036D0 (en) * | 1988-05-10 | 1988-06-15 | Glaxo Group Ltd | Chemical compounds |
| GB8813760D0 (en) * | 1988-06-10 | 1988-07-13 | American Cyanamid Co | Chemical process |
| GB8815967D0 (en) * | 1988-07-05 | 1988-08-10 | Pfizer Ltd | Antiparasitic agents |
| NZ231772A (en) * | 1988-12-23 | 1992-11-25 | Merck & Co Inc | Avermectin derivatives, preparation and parasiticidal compositions thereof |
| NZ231773A (en) * | 1988-12-23 | 1992-09-25 | Merck & Co Inc | Avermectin derivatives, preparation and parasiticidal pharmaceutical compositions thereof |
| US5015630A (en) * | 1989-01-19 | 1991-05-14 | Merck & Co., Inc. | 5-oxime avermectin derivatives |
| US4897383A (en) * | 1989-02-13 | 1990-01-30 | Merck & Co., Inc. | Avermectin derivatives |
| US5252474A (en) * | 1989-03-31 | 1993-10-12 | Merck & Co., Inc. | Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use |
| US5030622A (en) * | 1989-06-02 | 1991-07-09 | Merck & Co., Inc. | Avermectin derivatives |
| US5057499A (en) * | 1989-06-02 | 1991-10-15 | Merck & Co. Inc. | Avermectin derivatives |
| US5023241A (en) * | 1989-07-31 | 1991-06-11 | Merck & Co., Inc. | Avermectin derivatives |
| US5830875A (en) * | 1989-10-30 | 1998-11-03 | Merck & Co., Inc. | 24-and 25-substituted avermectin and milbemycin derivatives |
| JP2888586B2 (ja) * | 1990-03-05 | 1999-05-10 | 社団法人北里研究所 | エバーメクチンの特定成分を選択生産するための微生物およびその選択的製造法 |
| US5169839A (en) * | 1990-05-11 | 1992-12-08 | Merck & Co., Inc. | Derivatives of 3'- and 3"-o-desmethyl avermectin compounds, compositions and methods of treating melmintic and parasitic infections |
| US5208222A (en) * | 1991-03-28 | 1993-05-04 | Merck & Co., Inc. | 4"-and 4'-alkylthio avermectin derivatives |
| US5240915A (en) * | 1991-10-15 | 1993-08-31 | Merck & Co., Inc. | Avermectin derivatives |
| US6103504A (en) * | 1992-03-25 | 2000-08-15 | Pfizer Inc. | Process for production of avermectins and cultures therefor |
| US5292647A (en) * | 1992-11-30 | 1994-03-08 | Eli Lilly And Company | Strain of streptomyces for producing avermectins and processes therewith |
| CN1038330C (zh) * | 1993-07-05 | 1998-05-13 | 塞泰克斯公司 | 阿弗麦菌素的生产与分离 |
| EP0711349B1 (de) * | 1993-07-30 | 2003-09-03 | Pfizer Inc. | Gene, die verzweigte-alpha-ketosäure-dehydrogenasekomplexe von streptomyces avermitius kodieren |
| JP2761296B2 (ja) * | 1993-10-05 | 1998-06-04 | フアイザー・インコーポレイテツド | ドラメクチンの製造方法および駆虫性中間体 |
| FI942725A (fi) * | 1993-12-16 | 1995-06-17 | Pfizer | Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta |
| US5701591A (en) * | 1995-04-07 | 1997-12-23 | Telecommunications Equipment Corporation | Multi-function interactive communications system with circularly/elliptically polarized signal transmission and reception |
| CN1297485A (zh) * | 1998-02-13 | 2001-05-30 | 辉瑞产品公司 | 介导除虫菌素b2:b1比例的除虫链霉菌基因 |
| IL147563A0 (en) * | 1999-08-12 | 2002-08-14 | Pfizer Prod Inc | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| KR100415395B1 (ko) * | 2000-08-02 | 2004-01-16 | 한국생명공학연구원 | 에버멕틴 ｂｃ-5-ｏ-메칠트랜스퍼라제의 유전자가 파괴된 스트렙토마이세스 에버미티리스 변이균주 및 그의 제조 방법 |
| ES2373629T3 (es) | 2002-02-12 | 2012-02-07 | Pfizer Products Inc. | Gen de streptomyces avemitilis que dirige la proporción de avermectinas b2:b1. |
| WO2023203038A1 (en) | 2022-04-19 | 2023-10-26 | Syngenta Crop Protection Ag | Insect, acarina and nematode pest control |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE434277B (sv) | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
| NZ188459A (en) * | 1977-10-03 | 1982-09-07 | Merck & Co Inc | Derivatives of c-076 compounds and pesticidal compositions |
| US4429042A (en) | 1978-09-08 | 1984-01-31 | Merck & Co., Inc. | Strain of Streptomyces for producing antiparasitic compounds |
| ES8800986A1 (es) * | 1985-07-27 | 1987-12-01 | Pfizer | Un procedimiento para la produccion de un nuevo derivado de avermectina |
| GB8606120D0 (en) * | 1986-03-12 | 1986-04-16 | Glaxo Group Ltd | Process |
-
1987
- 1987-12-10 IN IN1059/DEL/87A patent/IN167980B/en unknown
-
1988
- 1988-01-18 BG BG082657A patent/BG51051A3/xx unknown
- 1988-01-18 EP EP88300354A patent/EP0276103B1/de not_active Expired - Lifetime
- 1988-01-18 ES ES88300354T patent/ES2059498T3/es not_active Expired - Lifetime
- 1988-01-18 AT AT88300354T patent/ATE96174T1/de not_active IP Right Cessation
- 1988-01-18 IL IL85118A patent/IL85118A/xx not_active IP Right Cessation
- 1988-01-18 DE DE88300354T patent/DE3884973T2/de not_active Expired - Lifetime
- 1988-01-19 MA MA21397A patent/MA21160A1/fr unknown
- 1988-01-19 MY MYPI88000037A patent/MY103514A/en unknown
- 1988-01-20 ES ES88300426T patent/ES2053719T3/es not_active Expired - Lifetime
- 1988-01-20 AT AT88300426T patent/ATE87927T1/de not_active IP Right Cessation
- 1988-01-20 EP EP88300426A patent/EP0276131B1/de not_active Expired - Lifetime
- 1988-01-20 DE DE8888300426T patent/DE3879975T2/de not_active Expired - Lifetime
- 1988-01-21 SK SK407-88A patent/SK279351B6/sk unknown
- 1988-01-21 EG EG3588A patent/EG18797A/xx active
- 1988-01-21 PT PT86583A patent/PT86583B/pt unknown
- 1988-01-21 PT PT86584A patent/PT86584B/pt unknown
- 1988-01-21 PL PL1988270238A patent/PL156763B1/pl unknown
- 1988-01-21 CZ CS88407A patent/CZ279782B6/cs unknown
- 1988-01-21 PL PL1988270239A patent/PL156764B1/pl unknown
- 1988-01-21 IL IL85165A patent/IL85165A/xx not_active IP Right Cessation
- 1988-01-22 YU YU11988A patent/YU47878B/sh unknown
- 1988-01-22 ZA ZA88448A patent/ZA88448B/xx unknown
- 1988-01-22 CN CN88100649A patent/CN1056883C/zh not_active Expired - Lifetime
- 1988-01-22 IE IE16188A patent/IE61066B1/en not_active IP Right Cessation
- 1988-01-22 HU HU88260D patent/HU201973B/hu unknown
- 1988-01-22 FI FI880280A patent/FI90091C/fi not_active IP Right Cessation
- 1988-01-22 DD DD88312393A patent/DD290214A5/de unknown
- 1988-01-22 JP JP63012462A patent/JPH0681757B2/ja not_active Expired - Lifetime
- 1988-01-22 DK DK028988A patent/DK28988A/da not_active Application Discontinuation
- 1988-01-22 AR AR88309888A patent/AR241798A1/es active
- 1988-01-22 HU HU88261A patent/HU200487B/hu unknown
- 1988-01-22 ZA ZA88449A patent/ZA88449B/xx unknown
- 1988-01-22 ZA ZA88447A patent/ZA88447B/xx unknown
- 1988-01-22 DK DK198800290A patent/DK175720B1/da not_active IP Right Cessation
- 1988-01-22 IE IE16088A patent/IE61483B1/en not_active IP Right Cessation
- 1988-01-22 NZ NZ223271A patent/NZ223271A/en unknown
- 1988-01-22 DD DD88312394A patent/DD267512A5/de unknown
- 1988-01-22 NZ NZ223272A patent/NZ223272A/xx unknown
- 1988-01-22 FI FI880281A patent/FI90088C/fi not_active IP Right Cessation
- 1988-01-22 RU SU884355079A patent/RU1806198C/ru active
- 1988-01-22 AU AU10696/88A patent/AU595673B2/en not_active Expired
- 1988-01-22 KR KR1019880000470A patent/KR900004419B1/ko not_active IP Right Cessation
- 1988-01-23 KR KR1019880000506A patent/KR910002225B1/ko not_active IP Right Cessation
- 1988-01-23 JP JP63011881A patent/JPH0817693B2/ja not_active Expired - Lifetime
- 1988-01-25 BR BRPI8800271-3A patent/BR8800271A/pt not_active IP Right Cessation
-
1991
- 1991-02-15 AU AU71110/91A patent/AU631298B2/en not_active Expired
-
1993
- 1993-04-08 GR GR930400638T patent/GR3007586T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG51051A3 (en) | Process for production of b avermektins | |
| KR850000530A (ko) | 루신 유도체의 제조방법 | |
| BG48572A3 (en) | Method for preparing of avermectines | |
| ES8203421A1 (es) | Un procedimiento para la preparacion de acido griseolico | |
| DE3878564D1 (de) | Verfahren zur mikrobiologischen herstellung von 1,3-propandiol aus glycerin. | |
| DK0387178T3 (da) | Ny fremgangsmåde til fremstilling af Z (2R,5R)-3-(2-hydroxyethyliden)-7-oxo-4-oxa-1-azabicyclo(3,2,0)-heptan-2-carboxylsyre og farmaceutisk acceptable salte og estere deraf ud fra fermenteringsmedier med Streptomyces sp. | |
| ES452363A1 (es) | Un procedimiento para la preparacion de acido clavulanico y sus sales. | |
| IL79036A (en) | Process for the preparation of s-2-arylpropionic acids by microbiological asymmetric oxidation of the corresponding 2-arylpropane | |
| ES445965A1 (es) | Procedimiento para la obtencion de nuevo antibiotico papula-candina. | |
| ES444311A1 (es) | Un procedimiento de lisis del residuo micelar obtenido en laproduccion de antibioticos. | |
| GB1514389A (en) | Glycerides with antibacterial properties | |
| GB1554395A (en) | Method for producing maytansinol and its derivatives | |
| DK627587D0 (da) | Fremgangsmaade til fremstilling af 2-arylprpionsyrer og mikroorganismer anvendt ved denne fremgangsmaade | |
| GB1500965A (en) | Cyclic ether antibiotics | |
| GB1111010A (en) | Process for the production of the antibiotic pleuromutilin | |
| KR890701752A (ko) | 천연 메틸 안트라닐레이트의 제조방법 | |
| SE8202201L (sv) | Forfarande for intjockning av biologiskt slam, serskilt aktivt slam | |
| GB1499710A (en) | Fluidized bed waste incineration process | |
| KR900018384A (ko) | 항생제 아라노로신, 이의 미생물학적 제조방법 및 이의 약제로서의 용도 | |
| JPS5486690A (en) | Preparation of 3-hydroxy-3-methylglutaric acid | |
| SU619506A1 (ru) | Способ выращивани микроорганизмов | |
| GB1430842A (en) | Method of producing l-lysine by fermentation | |
| GB908976A (en) | Process for the manufacture of í~-dehydrosteroids | |
| JPS5212993A (en) | Method of producing antibiotics | |
| JPS55144887A (en) | Preparation of physiologically active substance |